243 related articles for article (PubMed ID: 17296813)
1. Management of gastroesophageal tumors.
Gee DW; Rattner DW
Oncologist; 2007 Feb; 12(2):175-85. PubMed ID: 17296813
[TBL] [Abstract][Full Text] [Related]
2. Cancer of the gastroesophageal junction: combined modality therapy.
Ilson DH
Surg Oncol Clin N Am; 2006 Oct; 15(4):803-24. PubMed ID: 17030275
[TBL] [Abstract][Full Text] [Related]
3. Diagnosis and treatment of non-metastatic esophagogastric junction adenocarcinoma: what are the current options?
Gronnier C; Piessen G; Mariette C
J Visc Surg; 2012 Feb; 149(1):e23-33. PubMed ID: 22341763
[TBL] [Abstract][Full Text] [Related]
4. Cancer of the esophagogastric junction.
Stein HJ; Feith M; Siewert JR
Surg Oncol; 2000 Jul; 9(1):35-41. PubMed ID: 11525305
[TBL] [Abstract][Full Text] [Related]
5. Prognostic factors in adenocarcinoma of the esophagus or gastroesophageal junction.
Lagarde SM; ten Kate FJ; Reitsma JB; Busch OR; van Lanschot JJ
J Clin Oncol; 2006 Sep; 24(26):4347-55. PubMed ID: 16963732
[TBL] [Abstract][Full Text] [Related]
6. [Multimodality therapy for adenocarcinoma of the esophagogastric junction].
He J; Huang JF
Zhonghua Wei Chang Wai Ke Za Zhi; 2012 Sep; 15(9):877-80. PubMed ID: 22990915
[TBL] [Abstract][Full Text] [Related]
7. [Understanding and controversy of the gastroesophageal junction adenocarcinoma].
Zhang XH; Wang QZ
Zhonghua Zhong Liu Za Zhi; 2008 Dec; 30(12):947-9. PubMed ID: 19174001
[No Abstract] [Full Text] [Related]
8. Oesophagectomy for tumours and dysplasia of the oesophagus and gastro-oesophageal junction.
Epari K; Cade R
ANZ J Surg; 2009 Apr; 79(4):251-7. PubMed ID: 19432710
[TBL] [Abstract][Full Text] [Related]
9. [Treatment of the esophago-gastric junction adenocarcinoma].
Bîrlă R; Losif C; Gîndea C; Hoară P; Constantinoiu S
Chirurgia (Bucur); 2008; 103(2):143-53. PubMed ID: 18457092
[TBL] [Abstract][Full Text] [Related]
10. Gastroesophageal junction adenocarcinoma: what are the factors influencing long-term survival?
del Genio A; Rossetti G; Maffettone V; Napolitano V; Brusciano L; del Genio G; Russo G; Limongelli P; Fiume I; Pizza F; Tolone S; Di Martino M
Int Surg; 2006; 91(3):174-80. PubMed ID: 16845860
[TBL] [Abstract][Full Text] [Related]
11. Esophagogastric junction and gastric adenocarcinoma: neoadjuvant and adjuvant therapy, and future directions.
Sandler S
Oncology (Williston Park); 2014 Jun; 28(6):505-12. PubMed ID: 25134325
[TBL] [Abstract][Full Text] [Related]
12. Role of neoadjuvant therapy for esophageal adenocarcinoma.
Ku GY; Ilson DH
Surg Oncol Clin N Am; 2009 Jul; 18(3):533-46. PubMed ID: 19500742
[TBL] [Abstract][Full Text] [Related]
13. Surgical management of gastroesophageal junction tumors.
Amenabar A; Hoppo T; Jobe BA
Semin Radiat Oncol; 2013 Jan; 23(1):16-23. PubMed ID: 23207043
[TBL] [Abstract][Full Text] [Related]
14. Transition in biology and philosophy in the treatment of gastroesophageal junction adenocarcinoma.
Tepper JE; O'Neil B
J Clin Oncol; 2009 Feb; 27(6):836-7. PubMed ID: 19139425
[No Abstract] [Full Text] [Related]
15. Management of Locally Advanced Adenocarcinoma of the Esophagus and Gastroesophageal Junction: Finally a Consensus.
Kleinberg L; Brock M; Gibson M
Curr Treat Options Oncol; 2015 Jul; 16(7):35. PubMed ID: 26112428
[TBL] [Abstract][Full Text] [Related]
16. Therapy for locally advanced adenocarcinoma of the gastroesophageal junction: optimizing outcome.
Kleinberg L
Semin Radiat Oncol; 2013 Jan; 23(1):38-50. PubMed ID: 23207046
[TBL] [Abstract][Full Text] [Related]
17. Management of gastroesophageal junction tumors.
Fox MP; van Berkel V
Surg Clin North Am; 2012 Oct; 92(5):1199-212. PubMed ID: 23026278
[TBL] [Abstract][Full Text] [Related]
18. Multimodality therapy of local regional esophageal cancer.
Kelsen DP
Semin Oncol; 2005 Dec; 32(6 Suppl 9):S6-10. PubMed ID: 16399422
[TBL] [Abstract][Full Text] [Related]
19. It is time for a proper staging system for adenocarcinoma of the gastroesophageal junction.
Pedrazzani C; de Manzoni G; Marrelli D; Roviello F
J Clin Oncol; 2007 Mar; 25(7):907-8; author reply 908-9. PubMed ID: 17327616
[No Abstract] [Full Text] [Related]
20. Optimal management of esophageal adenocarcinoma: should we be CROSS?
Smyth EC; Waddell TS; Cunningham D
J Clin Oncol; 2014 Sep; 32(27):3080-1. PubMed ID: 25071100
[No Abstract] [Full Text] [Related]
[Next] [New Search]
